0 NASDAQ Companies - February 14, 2019Orgenesis Reports 85% Increase in Revenue and 139% Increase in Gross Profit for Fiscal 2018Expands POCare platform through a variety of valuable collaboration agreements GERMANTOWN, Md., Feb. 14, 2019 (GLOBE NEWSWIRE) — Orgenesis Inc. […]Read More
0 NASDAQ Companies - February 14, 2019Eloxx Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference in New York City on Friday, March 1, 2019WALTHAM, Mass., Feb. 14, 2019 (GLOBE NEWSWIRE) — Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the […]Read More
0 NYSE Companies - February 14, 2019Toll Brothers’ Website to Broadcast its February 27, 2019 First Quarter 2019 Earnings Conference Call LiveHORSHAM, Pa., Feb. 14, 2019 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, will […]Read More
0 NASDAQ Companies - February 14, 2019Ultragenyx and Kyowa Kirin Announce Positive 64-Week Results for Crysvita® (burosumab) from Phase 3 Study in Children with X-linked Hypophosphatemia (XLH)Results Confirm and Extend 40-Week Findings that Treatment with Crysvita is Superior to Conventional Therapy NOVATO, Calif., TOKYO and LONDON, […]Read More
0 NASDAQ Companies - February 14, 2019Sarepta Announces FDA Acceptance of Golodirsen (SRP-4053) New Drug Application for Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53— FDA Grants Priority Review Status — — Regulatory Action Date is August 19, 2019 — — Golodirsen has been studied […]Read More
0 NASDAQ Companies - February 14, 2019Achaogen Submits Response to ASPR/BARDA Request for Information (RFI) for Antimicrobial Resistance Project BioShield— Plazomicin may be well-suited to play a critical role in biodefense preparedness — SOUTH SAN FRANCISCO, Calif., Feb. 14, […]Read More
0 NASDAQ Companies - February 14, 2019Achaogen Provides Update on Corporate Progress and Key Preliminary Fourth Quarter 2018 Results— Company provides update on ZEMDRI® commercialization and launch — — Data from both the EPIC and CARE Phase 3 clinical studies […]Read More
0 NASDAQ Companies - February 14, 2019Richard Brudnick to Join InflaRx Board of DirectorsJENA, Germany, Feb. 14, 2019 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), an innovative biopharmaceutical company developing anti-inflammatory therapeutics by […]Read More
0 NASDAQ Companies - February 14, 2019US District Court Adopts Finjan’s Claim Constructions Over Cisco’sThree Patents, Four Disputed Claim Terms, 100% Win for Finjan, Inc. EAST PALO ALTO, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) […]Read More
0 TSX Venture News - February 14, 2019Pan Orient Energy Corp. Operations UpdateCALGARY, Alberta, Feb. 14, 2019 (GLOBE NEWSWIRE) — Pan Orient Energy Corp. (“Pan Orient”) (POE – TSXV) is providing an […]Read More